PHENEX PHARMACEUTICALS
Phenex Pharmaceuticals AG was founded in 2002. It is a privately held drug discovery & development company based in the Biotech Cluster Rhine-Neckar with Biology and Chemistry laboratories and offices primarily in Heidelberg and partly in Ludwigshafen. Their company focuses its small-molecule drug discovery expertise in Liver and Gastrointestinal disease areas and has now recently entered the field of Cancer Therapy. They not only devise novel therapeutics for known targets but additionally aim... to identify novel molecular mechanisms. This provides the basis for the identification of novel small molecules with "game changing" capabilities. Historically, Phenex has identified two of such novel mechanisms from literature and has translated them into proprietary novel therapeutic small molecules.
PHENEX PHARMACEUTICALS
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2002-01-01
Address:
Heidelberg, Baden-Wurttemberg, Germany
Country:
Germany
Website Url:
http://www.phenex-pharma.com
Total Employee:
11+
Status:
Active
Contact:
49 621 671960 0
Email Addresses:
[email protected]
Total Funding:
32.75 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Apache Wordpress Plugins Mobile Non Scaleable Content
Similar Organizations
Ability Pharmaceuticals
Ability Pharmaceuticals is a drug discovery and development company.
Ablynx
Ablynx is a biopharmaceutical company engaged in the discovery and development of nanobodies.
ImmuPharma
ImmuPharma plc is a United Kingdom-based drug discovery and development company. The Company is focused on developing drugs.
NGM Biopharmaceuticals
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
SalvaRx Group PLC
SalvaRx Group PLC is a drug discovery and development company focused on immune-oncology & invests in novel cancer immune-therapies.
Somai Pharmaceuticals Ltd
Somai is a European pharmaceutical and biotech company concentrating on cannabinoid-containing pharmaceutical medicines.
Targetrin Therapeutics
Targetrin Therapeutics develop novel drug candidates through the unique combination of industry leading novel cyclodextrin R&D and cGMP.
Current Advisors List
Current Employees Featured
Founder
Investors List
KfW
KfW investment in Series C - Phenex Pharmaceuticals
CD-Venture
CD-Venture investment in Series C - Phenex Pharmaceuticals
EVP Capital Management
EVP Capital Management investment in Series C - Phenex Pharmaceuticals
Swiss Life Private Equity Partners
Swiss Life Private Equity Partners investment in Series C - Phenex Pharmaceuticals
Creathor Ventures
Creathor Ventures investment in Series C - Phenex Pharmaceuticals
LBBW VC
LBBW VC investment in Series C - Phenex Pharmaceuticals
COI Partners
COI Partners investment in Venture Round - Phenex Pharmaceuticals
LBBW VC
LBBW VC investment in Series B - Phenex Pharmaceuticals
Creathor Ventures
Creathor Ventures investment in Series B - Phenex Pharmaceuticals
KfW
KfW investment in Series B - Phenex Pharmaceuticals
Official Site Inspections
http://www.phenex-pharma.com
- Host name: 217-160-0-111.elastic-ssl.ui-r.com
- IP address: 217.160.0.111
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Phenex Pharmaceuticals"
Phenex Pharmaceuticals AG - Drug pipelines, Patents, Clinical trials ...
Explore Phenex Pharmaceuticals AG with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, 7 news, and 40 literature, Disease Domain:Neoplasms, Endocrinology and …See details»
Phenex Pharmaceuticals AG - LinkedIn
Phenex Pharmaceuticals AG was founded in 2002. It is a privately owned drug discovery & development company based in the Biotech Cluster Rhine-Neckar in Heidelberg.See details»
Phenex Pharmaceuticals AG - Heidelberg, Germany - bionity.com
Dec 20, 2012 Phenex Pharmaceuticals AG was founded in 2002. It is a privately owned drug discovery & development company based in the Biotech Cluster Rhine-Neckar in Heidelberg. …See details»
Phenex Pharmaceuticals Company Profile | Management and
Phenex Pharmaceuticals Profile and History Phenex is a privately held drug discovery and development company headquartered in Heidelberg. The biopharmaceutical company can …See details»
Phenex Pharmaceuticals (Phenex Pharmaceuticals AG) - Startbase
Official Website: phenex-pharma.com; On Social Media: Legal Entity: Phenex Pharmaceuticals AG Location: Baden-Württemberg Overview Company Team News Is this your company? …See details»
Phenex Pharmaceuticals - Products, Competitors, Financials, …
Phenex Pharmaceuticals AG, founded in 2002, is a privately held Drug Discovery & Development company based in the Biotech Cluster Rhine-Neckar. Use the CB Insights Platform to explore …See details»
Phenex Pharmaceuticals AG - Company Profile and News
Phenex Pharmaceuticals AG develops medical drugs. The Company specializes in small-molecule drug discovery with nuclear receptors with applications in hormone replacement …See details»
Phenex Pharmaceuticals Company Profile - Craft
Phenex Pharmaceuticals is a company focusing its small-molecule drug discovery expertise on liver diseases and cancer. ... Founded 2002 HQ Heidelberg, DE | view all locations Website …See details»
Phenex Pharma - Company Profile - Tracxn
Sep 6, 2024 Phenex Pharma - Developer of small molecules targeting nuclear receptors for the treatment of liver diseases & autoimmune diseases. Raised a total funding of $24.5M over 3 …See details»
Phenex Pharmaceuticals AG - Ludwigshafen am Rhein, Deutschland
Die Phenex Pharmaceuticals AG betreibt Wirkstoffforschung an Nukleären Rezeptoren mit dem Ziel, neue Medikamente gegen Stoffwechsel- und Autoimmunkrankheiten zu entwickeln. …See details»
Phenex Pharmaceuticals AG - BioCentury Company Profiles - BCIQ
Nov 1, 2022 Phenex Pharmaceuticals AG - BioCentury Company Profiles for the biopharma industrySee details»
Janssen, Phenex Pharma enter research collaboration
Dec 19, 2012 Janssen has entered into a collaboration agreement with Phenex Pharmaceuticals AG, a German drug discovery company that focuses on developing innovative small molecule …See details»
Gilead Sciences Announces Acquisition of Phenex Pharmaceuticals ...
Jan 6, 2015 About Phenex Pharmaceuticals AG. Phenex is a small private German biotechnology company founded in 2002 and located in Ludwigshafen, Germany, with a …See details»
Phenex Pharmaceuticals | EquityNet
Phenex is a privately financed biotechnology company that focuses on developing novel drug candidates that act on Nuclear Receptors, a pharmacologically well accepted drug target …See details»
Phenex Pharmaceuticals AG - Ludwigshafen am Rhein, Germany
Phenex is an innovative drug discovery company focusing on the important drug target class of Nuclear Receptors. The company has assembled a powerful drug discovery toolbox for …See details»
Gilead Sciences Acquires a Phenex Pharmaceuticals’ Development …
Jan 6, 2015 Gilead will pay Phenex an upfront payment plus additional payments based upon certain development milestones that may potentially be worth up to $470 million. “This …See details»
Gilead Sciences to Acquire Phenex Pharmaceuticals' Non-Alcoholic ...
Jan 6, 2015 Gilead Sciences and Phenex Pharmaceuticals AG today announced the signing of a definitive agreement under which Gilead will acquire Phenex’s Farnesoid X Receptor (FXR) …See details»
Discovery of Small Molecule Aryl Hydrocarbon Receptor (AhR)
Phenex interested in targets that break the `metabolic shield` of solid tumors. Discovery on Target, Boston, Sept. 17, 2019 4. Crystal structure of AhR/ARNT complex bound to its. target …See details»
Targeting the IDO1-Kynurenine-AhR pathway for cancer …
Fig. 4 Phenex AhR small molecules antagonize natural as well as synthetic AhR agonistin a HepG2-CYP1A1-Luciferase reporter cells. 10-2 10 0 10 2 10 4 10 6 0 2000 4000 6000 …See details»